Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Normally I'd agree - but on 3yr paper

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
10nisman Member Profile
 
Followed By 6
Posts 1,499
Boards Moderated 0
Alias Born 10/26/03
160x600 placeholder
S&P 500 Rises To Record, Nabs Best Month Since February
U.S. stocks closed with modest gains Friday in light trading, building on weekly and monthly advances, as largely upbeat U.S. economic data offset overseas worries.
Top Equities Stories Of The Day
J.P. Morgan Working With Law Enforcement on Cyber Attack -- Update
Apple Continues To Rise On IPhone Hype
Ex-LPL Broker Ordered to Pay Nearly $2 Million
J.P. Morgan Working With Law Enforcement on Cyber Attack -- 3rd Update
U.S. Hot Stocks: Hot Stocks to Watch
U.S. Hot Stocks: Hot Stocks to Watch
Amazon, Twitter Gains Lead Techs Higher
Amazon Among Gainers In Mild Tech Trading
10nisman   Thursday, 09/23/10 12:08:13 PM
Re: wallstarb post# 104887
Post # of 181547 
Quote:
Normally I'd agree - but on 3yr paper it doesnt have the duration for a longer term investment, and unless MSFT is buying junk bonds with it I really dont see the point for them. Perhaps an acquisition on the horizon - or maybe they are buying some CMOs

The vast majority of MSFT's cash is overseas and thus to get around paying taxes to repatriate it they chose to issue debt at insanely attractive levels. MSFT will likely use the cash to pay its dividend and buy-back shares.

10nis

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist